Population-adjusted rates of initial antihypertensive prescriptions per 1,000 elderly Ontario residents with diabetes and newly treated for hypertension, total and by sex
| . | 1995 . | 1996 . | 1997 . | 1998 . | 1999 . | 2000 . | 2001 . |
|---|---|---|---|---|---|---|---|
| Total | |||||||
| ACE inhibitors | 7.57 | 8.52 | 9.72 | 10.0 | 12.84 | 17.01 | 15.40 |
| Angiotensin II receptor blockers | 0.04 | 0.10 | 0.17 | 0.20 | 0.24 | 0.35 | |
| β-Blockers | 0.95 | 1.14 | 1.09 | 1.18 | 1.20 | 1.15 | 1.13 |
| Calcium channel blockers | 2.26 | 2.00 | 1.67 | 1.38 | 1.49 | 1.32 | 1.18 |
| Combination agents | 0.06 | 0.03 | 0.11 | 0.07 | 0.12 | 0.14 | 0.18 |
| Thiazides | 3.07 | 2.90 | 2.78 | 2.68 | 2.77 | 2.64 | 2.08 |
| Any antihypertensive | 13.91 | 14.63 | 15.47 | 15.48 | 18.63 | 22.50 | 20.32 |
| Women | |||||||
| ACE inhibitors | 6.77 | 7.59 | 8.60 | 8.71 | 11.00 | 14.39 | 13.50 |
| Angiotensin II receptor blockers | 0.03 | 0.13 | 0.19 | 0.19 | 0.27 | 0.41 | |
| β-Blockers | 0.92 | 1.12 | 1.06 | 1.12 | 1.19 | 1.06 | 1.16 |
| Calcium channel blockers | 2.25 | 2.21 | 1.68 | 1.33 | 1.49 | 1.34 | 1.20 |
| Combination agents | 0.08 | 0.03 | 0.14 | 0.09 | 0.13 | 0.13 | 0.19 |
| Thiazides | 3.48 | 3.46 | 3.31 | 2.99 | 3.19 | 3.07 | 2.41 |
| Any antihypertensive | 13.49 | 14.43 | 14.92 | 14.43 | 17.19 | 20.26 | 18.87 |
| Men | |||||||
| ACE inhibitors | 8.47 | 9.55 | 10.95 | 11.44 | 14.85 | 19.85 | 17.44 |
| Angiotensin II receptor blockers | 0.04 | 0.07 | 0.15 | 0.21 | 0.22 | 0.29 | |
| β-Blockers | 0.98 | 1.16 | 1.12 | 1.24 | 1.22 | 1.23 | 1.09 |
| Calcium channel blockers | 2.28 | 1.76 | 1.66 | 1.45 | 1.49 | 1.29 | 1.15 |
| Combination agents | 0.04 | 0.02 | 0.08 | 0.06 | 0.11 | 0.16 | 0.17 |
| Thiazides | 2.62 | 2.27 | 2.19 | 2.33 | 2.32 | 2.18 | 1.74 |
| Any antihypertensive | 14.37 | 14.82 | 16.07 | 16.66 | 20.21 | 24.94 | 21.89 |
| . | 1995 . | 1996 . | 1997 . | 1998 . | 1999 . | 2000 . | 2001 . |
|---|---|---|---|---|---|---|---|
| Total | |||||||
| ACE inhibitors | 7.57 | 8.52 | 9.72 | 10.0 | 12.84 | 17.01 | 15.40 |
| Angiotensin II receptor blockers | 0.04 | 0.10 | 0.17 | 0.20 | 0.24 | 0.35 | |
| β-Blockers | 0.95 | 1.14 | 1.09 | 1.18 | 1.20 | 1.15 | 1.13 |
| Calcium channel blockers | 2.26 | 2.00 | 1.67 | 1.38 | 1.49 | 1.32 | 1.18 |
| Combination agents | 0.06 | 0.03 | 0.11 | 0.07 | 0.12 | 0.14 | 0.18 |
| Thiazides | 3.07 | 2.90 | 2.78 | 2.68 | 2.77 | 2.64 | 2.08 |
| Any antihypertensive | 13.91 | 14.63 | 15.47 | 15.48 | 18.63 | 22.50 | 20.32 |
| Women | |||||||
| ACE inhibitors | 6.77 | 7.59 | 8.60 | 8.71 | 11.00 | 14.39 | 13.50 |
| Angiotensin II receptor blockers | 0.03 | 0.13 | 0.19 | 0.19 | 0.27 | 0.41 | |
| β-Blockers | 0.92 | 1.12 | 1.06 | 1.12 | 1.19 | 1.06 | 1.16 |
| Calcium channel blockers | 2.25 | 2.21 | 1.68 | 1.33 | 1.49 | 1.34 | 1.20 |
| Combination agents | 0.08 | 0.03 | 0.14 | 0.09 | 0.13 | 0.13 | 0.19 |
| Thiazides | 3.48 | 3.46 | 3.31 | 2.99 | 3.19 | 3.07 | 2.41 |
| Any antihypertensive | 13.49 | 14.43 | 14.92 | 14.43 | 17.19 | 20.26 | 18.87 |
| Men | |||||||
| ACE inhibitors | 8.47 | 9.55 | 10.95 | 11.44 | 14.85 | 19.85 | 17.44 |
| Angiotensin II receptor blockers | 0.04 | 0.07 | 0.15 | 0.21 | 0.22 | 0.29 | |
| β-Blockers | 0.98 | 1.16 | 1.12 | 1.24 | 1.22 | 1.23 | 1.09 |
| Calcium channel blockers | 2.28 | 1.76 | 1.66 | 1.45 | 1.49 | 1.29 | 1.15 |
| Combination agents | 0.04 | 0.02 | 0.08 | 0.06 | 0.11 | 0.16 | 0.17 |
| Thiazides | 2.62 | 2.27 | 2.19 | 2.33 | 2.32 | 2.18 | 1.74 |
| Any antihypertensive | 14.37 | 14.82 | 16.07 | 16.66 | 20.21 | 24.94 | 21.89 |